Litcius/Paper detail

Structure-based, multi-targeted drug discovery approach to eicosanoid inhibition: Dual inhibitors of mPGES-1 and 5-lipoxygenase activating protein (FLAP)

Joseph D. Ho, Matthew R. Lee, Charles T. Rauch, Kristen Aznavour, Jonathan S. Park, J.G. Luz, Stephen Antonysamy, Bradley Condon, Milan Maletic, Aiping Zhang, Michael J. Hickey, Norman E. Hughes, Srinivasan Chandrasekhar, Ashley V. Sloan, Karen M. Gooding, Anita K. Harvey, Xiaopeng Yu, Steven D. Kahl, Bryan H. Norman

2020Biochimica et Biophysica Acta (BBA) - General Subjects18 citationsDOIOpen Access PDF

Topics & Concepts

Drug discoveryPharmacophoreEicosanoidChemistryTarget proteinLigand (biochemistry)DrugIn vitroLipoxygenaseProstaglandinLeukotrieneBiochemistryEnzymeComputational biologyPharmacologyReceptorBiologyArachidonic acidGeneAsthmaImmunologyInflammatory mediators and NSAID effectsAsthma and respiratory diseasesEicosanoids and Hypertension Pharmacology
Structure-based, multi-targeted drug discovery approach to eicosanoid inhibition: Dual inhibitors of mPGES-1 and 5-lipoxygenase activating protein (FLAP) | Litcius